Pay in 4 interest-free payments of $6.97 Learn more
Ships within 48 hours · Estimated delivery Oct 24 - Oct 29
1 CT-388 is currently being evaluated in an additional Phase II study, CT388-104, designed to assess its efficacy, safety, and tolerability in participants living with obesity or overweight who also have type 2 diabetes
This level of weight loss is substantial and can be transformative, particularly for those facing health risks associated with obesity
Supports Fat Metabolism & Energy Conversion: L-Carnitine helps transport fatty acids into muscle cells, where they can be utilized as fuel, converting stored fat into clean, usable energy for improved workouts and daily performance
Semaglutide (Wegovy) In the pivotal STEP-1 trial, semaglutide 2.4 mg produced ~14.9% total body weight loss , significantly greater than placebo5
The effect of L-carnitine is reinforced with additional vitamin B6 which allows for a synergism of activity with L-carnitine in the energy generation processes occurring during intensive physical effort
US$ 27.95
:max_bytes(150000):strip_icc()/VWH-GettyImages-2126120259-c2442d334436484baa255439265b7fb1.jpg)
US$ 26.39
.jpg)
US$ 25.72
